eral counterdrug intelligence plan to im-
prove coordination, and eliminate unnec-
essary 
duplication, 
among 
the 
counterdrug intelligence centers and in-
formation 
sharing 
systems, 
and 
counterdrug activities of the Federal 
Government, including the centers, sys-
tems, and activities of the following de-
partments and agencies: 
(A) The Department of Defense, 
including the Defense Intelligence 
Agency, and the joint interagency 
task forces. 
(B) The Department of the Treas-
ury, including the Financial Crimes 
Enforcement Network (FinCEN). 
(C) The Central Intelligence Agen-
cy. 
(D) The National Security Agency. 
(E) The Department of Homeland 
Security, including the United States 
Coast Guard, the bureau of Customs 
and Border Protection, and the bu-
reau of Immigration and Customs En-
forcement. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00027
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
(F) The Department of Justice, in-
cluding 
the 
National 
Drug 
Intel-
ligence Center (NDIC); the Drug En-
forcement Administration, including 
the 
El 
Paso 
Intelligence 
Center 
(EPIC); the Federal Bureau of Inves-
tigation; the Organized Crime Drug 
Enforcement Task Force; and the Re-
gional Information Sharing System. 
(G) The Office of National Drug 
Control Policy, including the High In-
tensity Drug Trafficking Areas Pro-
gram. 
(H) The Counterdrug Intelligence 
Executive Secretariat. 
(2) PURPOSE.—The purpose of the plan 
under paragraph (1) is to maximize the 
effectiveness of the centers and activities 
referred to in that paragraph in achiev-
ing the objectives of the National Drug 
Control Strategy promulgated under 21 
U.S.C. 1705. In order to maximize such ef-
fectiveness, the plan shall— 
(A) articulate clear and specific 
mission statements (including pur-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00028
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
pose and scope of activity) for each 
counterdrug intelligence center, sys-
tem, and activity, including the man-
ner 
in 
which 
responsibility 
for 
counterdrug 
intelligence 
activities 
will 
be 
allocated 
among 
the 
counterdrug intelligence centers and 
systems; 
(B) 
specify 
each 
government 
agency (whether Federal, State, or 
local) that participates in each such 
center, system, and activity, including 
a description of the extent and nature 
of that participation; 
(C) specify the relationship be-
tween such centers, systems, and ac-
tivities; 
(D) specify the means by which 
proper oversight of such centers, sys-
tems, and activities will be assured; 
(E) specify the means by which 
counterdrug intelligence and infor-
mation will be forwarded effectively 
to all levels of officials responsible for 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00029
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
United 
States 
counterdrug 
policy; 
and 
(F) specify mechanisms to ensure 
that State and local law enforcement 
agencies are apprised of counterdrug 
intelligence and information acquired 
by Federal law enforcement agencies 
in a manner which— 
(i) 
facilitates 
effective 
counterdrug activities by State 
and local law enforcement agen-
cies; and 
(ii) provides such State and 
local law enforcement agencies 
with the information relating to 
the safety of officials involved in 
their counterdrug activities. 
(3) DEFINITIONS.—As used in this sub-
section— 
(A) the term ‘‘center’’ refers to any 
center, office, task force, or other co-
ordinating organization engaged in 
counterdrug intelligence or informa-
tion analyzing or sharing activities; 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00030
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
(B) the term ‘‘system’’ refers to 
any computerized database or other 
electronic 
system 
used 
for 
counterdrug intelligence or informa-
tion analyzing or sharing activities; 
and 
(C) the term ‘‘appropriate con-
gressional committees’’ means the fol-
lowing: 
(i) The Committee on Appro-
priations, the Committee on For-
eign Relations, the Committee on 
the Judiciary, the Committee on 
Homeland Security and Govern-
mental Affairs, the Caucus on 
International Narcotics Control, 
and the Select Committee on In-
telligence of the Senate. 
(ii) The Committee on Appro-
priations, 
the 
Committee 
on 
International Relations, the Com-
mittee on the Judiciary, the Com-
mittee on Government Reform, 
the Committee on Homeland Se-
curity, and the Permanent Select 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00031
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
Committee on Intelligence of the 
House of Representatives. 
(4) 
LIMITATION.—The 
general 
counterdrug intelligence plan shall not— 
(A) change existing agency au-
thorities or the laws governing inter-
agency relationships, but may include 
recommendations about changes to 
such authorities or laws; or 
(B) include any information about 
specific methods of obtaining, or 
sources of, intelligence or informa-
tion, or any information about spe-
cific 
individuals, 
cases, 
investiga-
tions, or operations. 
(5) CLASSIFIED
OR
LAW
ENFORCEMENT 
SENSITIVE
INFORMATION.—Any content of 
the general counterdrug intelligence plan 
that 
involves 
information 
classified 
under criteria established by an Execu-
tive order, or whose public disclosure, as 
determined by the Director of the Office 
of National Drug Control Policy, the Di-
rector of National Intelligence, or the 
head of any Federal Government agency 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00032
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
whose activities are described in the 
plan, would be detrimental to the law en-
forcement or national security activities 
of any Federal, State, or local agency, 
shall be presented to Congress separately 
from the rest of the report. 
(l) REQUIREMENT FOR SOUTHWEST BORDER 
COUNTERNARCOTICS STRATEGY.— 
(1) IN
GENERAL.—Not later than 120 
days after the date of enactment of this 
Act, and every two years thereafter, the 
Director of National Drug Control Policy 
shall submit to the Congress a Southwest 
Border Counternarcotics Strategy. 
(2) PURPOSES.—The Southwest Border 
Counternarcotics Strategy shall— 
(A) set forth the Government’s 
strategy for preventing the illegal 
trafficking of drugs across the inter-
national border between the United 
States and Mexico, including through 
ports of entry and between ports of 
entry on that border; 
(B) state the specific roles and re-
sponsibilities of the relevant National 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00033
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
Drug Control Program agencies (as 
defined in section 702 of the Office of 
National Drug Control Policy Reau-
thorization Act of 1998 (21 U.S.C. 
1701)) for implementing that strategy; 
and 
(C) identify the specific resources 
required to enable the relevant Na-
tional Drug Control Program agen-
cies to implement that strategy. 
(3) CONSULTATION
WITH
OTHER
AGEN-
CIES.—The Director shall issue the South-
west Border Counternarcotics Strategy in 
consultation with the heads of the rel-
evant National Drug Control Program 
agencies. 
(4) LIMITATION.—The Southwest Bor-
der Counternarcotics Strategy shall not 
change existing agency authorities or the 
laws governing interagency relationships, 
but may include recommendations about 
changes to such authorities or laws. 
(5) REPORT TO CONGRESS.—The Direc-
tor shall provide a copy of the Southwest 
Border Counternarcotics Strategy to the 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00034
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
appropriate congressional committees (as 
defined in section 702 of the Office of Na-
tional Drug Control Policy Reauthoriza-
tion Act of 1998 (21 U.S.C. 1701)), and to 
the Committee on Armed Services and 
the Committee on Homeland Security of 
the House of Representatives, and the 
Committee on Homeland Security and 
Governmental Affairs and the Committee 
on Armed Services of the Senate. 
(6) TREATMENT OF CLASSIFIED OR LAW 
ENFORCEMENT
SENSITIVE
INFORMATION.— 
Any content of the Southwest Border 
Counternarcotics Strategy that involves 
information classified under criteria es-
tablished by an Executive order, or 
whose public disclosure, as determined 
by the Director or the head of any rel-
evant National Drug Control Program 
agency, would be detrimental to the law 
enforcement or national security activi-
ties of any Federal, State, or local agency, 
shall be presented to Congress separately 
from the rest of the strategy. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00035
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
(m) REQUIREMENT FOR SCIENTIFIC STUDY OF 
MYCOHERBICIDE IN ILLICIT DRUG CROP ERADI-
CATION.—Not later than 90 days after the date 
of enactment of this Act, the Director of the 
Office of National Drug Control Policy shall 
submit to the Congress a report that includes 
a plan to conduct, on an expedited basis, a sci-
entific study of the use of mycoherbicide as a 
means of illicit drug crop elimination by an 
appropriate Government scientific research 
entity, including a complete and thorough sci-
entific peer review. The study shall include an 
evaluation of the likely human health and en-
vironmental impacts of such use. The report 
shall also include a plan to conduct controlled 
scientific testing in a major drug producing 
nation of mycoherbicide naturally existing in 
the producing nation. 
SEC. 107. AMENDMENTS RELATING TO COORDINATION 
WITH OTHER AGENCIES. 
Section 705 (21 U.S.C. 1704) is amended— 
(1) in subsection (a)(1)(A), by striking 
‘‘abuse’’; 
(2) in subsection (a)(2)(A), by striking 
‘‘Director of Central Intelligence’’ and in-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
serting 
‘‘Director 
of 
National 
Intel-
ligence’’; 
(3) in subsection (a)(2)(B), by striking 
‘‘Director of Central Intelligence’’ and in-
serting ‘‘Director of National Intelligence 
and the Director of the Central Intel-
ligence Agency’’; 
(4) by amending paragraph (3) of sub-
section (a) to read as follows: 
‘‘(3) REQUIRED REPORTS.— 
‘‘(A) SECRETARIES OF THE INTERIOR 
AND AGRICULTURE.—The Secretaries of 
Agriculture and Interior shall, by 
July 1 of each year, jointly submit to 
the Director, the appropriate con-
gressional committees, the Committee 
on Agriculture and the Committee on 
Resources of the House of Represent-
atives, and the Committee on Agri-
culture and the Committee on Energy 
and Natural Resources of the Senate, 
an assessment of the quantity of ille-
gal drug cultivation and manufac-
turing in the United States on lands 
owned or under the jurisdiction of 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00037
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
the Federal Government for the pre-
ceding year. 
‘‘(B) ATTORNEY GENERAL.—The At-
torney General shall, by July 1 of 
each year, submit to the Director and 
the appropriate congressional com-
mittees information for the preceding 
year regarding the number and type 
of— 
‘‘(i) arrests for drug viola-
tions; 
‘‘(ii) prosecutions for drug vio-
lations by United States Attor-
neys; and 
‘‘(iii) seizures of drugs by each 
component of the Department of 
Justice seizing drugs, as well as 
statistical information on the geo-
graphic areas of such seizures. 
‘‘(C) SECRETARY OF HOMELAND SE-
CURITY.—The Secretary of Homeland 
Security shall, by July 1 of each year, 
submit to the Director, the appro-
priate congressional committees, and 
the Committee on Homeland Security 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00038
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
of the House of Representatives, and 
the Committee on Homeland Security 
and Governmental Affairs of the Sen-
ate, information for the preceding 
year regarding— 
‘‘(i) the number and type of 
seizures of drugs by each compo-
nent of the Department of Home-
land Security seizing drugs, as 
well as statistical information on 
the geographic areas of such sei-
zures; and 
‘‘(ii) the number of air and 
maritime 
patrol 
hours 
under-
taken by each component of that 
Department primarily dedicated 
to drug supply reduction mis-
sions. 
‘‘(D) SECRETARY OF DEFENSE.—The 
Secretary of Defense shall, by July 1 
of each year, submit to the Director, 
the appropriate congressional com-
mittees, the Committee on Armed 
Services of the House of Representa-
tives, and the Committee on Armed 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00039
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
Services of the Senate, information 
for the preceding year regarding the 
number of air and maritime patrol 
hours primarily dedicated to drug 
supply 
reduction 
missions 
under-
taken by each component of the De-
partment of Defense.’’; 
(5) in subsection (b)(2)(B), by striking 
‘‘Program.’’ and inserting ‘‘Strategy.’’; and 
(6) in subsection (c), by striking ‘‘in’’ 
and inserting ‘‘on’’. 
SEC. 108. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
Section 706 (21 U.S.C. 1705) is amended to 
read as follows: 
‘‘SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
‘‘(a) TIMING, CONTENTS, AND PROCESS FOR 
DEVELOPMENT
AND SUBMISSION
OF NATIONAL 
DRUG CONTROL STRATEGY.— 
‘‘(1) IN GENERAL.—Not later than Feb-
ruary 1 of each year, the President shall 
submit to Congress a National Drug Con-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00040
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
trol Strategy, which shall set forth a com-
prehensive plan for reducing illicit drug 
use and the consequences of illicit drug 
use in the United States by reducing the 
demand for illegal drugs, limiting the 
availability of illegal drugs, and con-
ducting law enforcement activities with 
respect to illegal drugs. 
‘‘(2) CONTENTS.— 
‘‘(A) IN
GENERAL.—The National 
Drug 
Control 
Strategy 
submitted 
under paragraph (1) shall include the 
following: 
‘‘(i) Comprehensive, research- 
based, long-range, and quantifi-
able goals for reducing illicit drug 
use and the consequences of illicit 
drug use in the United States. 
‘‘(ii) Annual quantifiable ob-
jectives for demand reduction, 
supply reduction, and law en-
forcement activities, specific tar-
gets 
to 
accomplish 
long-range 
quantifiable reduction in illicit 
drug use as determined by the Di-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00041
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
rector, and specific measurements 
to evaluate progress toward the 
targets and strategic goals. 
‘‘(iii) A strategy to reduce the 
availability and purity of illegal 
drugs and the level of drug-re-
lated crime in the United States. 
‘‘(iv) An assessment of Federal 
effectiveness in achieving the Na-
tional Drug Control Strategy for 
the previous year, including a 
specific evaluation of whether the 
objectives and targets for reduc-
ing illicit drug use for the pre-
vious year were met and reasons 
for the success or failure of the 
previous year’s Strategy. 
‘‘(v) A general review of the 
status of, and trends in, inter-
national, State, and local drug 
control activities to ensure that 
the United States pursues well-co-
ordinated and effective drug con-
trol at all levels of government. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00042
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
‘‘(vi) A general review of the 
status of, and trends in, demand 
reduction activities by private 
sector entities and community- 
based 
organizations, 
including 
faith-based organizations, to de-
termine their effectiveness and 
the extent of cooperation, coordi-
nation, and mutual support be-
tween such entities and organiza-
tions and Federal, State, and local 
government agencies. 
‘‘(vii) An assessment of cur-
rent illicit drug use (including 
inhalants and steroids) and avail-
ability, impact of illicit drug use, 
and treatment availability, which 
assessment shall include— 
‘‘(I) 
estimates 
of 
drug 
prevalence and frequency of 
use as measured by national, 
State, and local surveys of il-
licit drug use and by other 
special 
studies 
of 
non-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00043
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
dependent and dependent il-
licit drug use; 
‘‘(II) illicit drug use in the 
workplace and the produc-
tivity lost by such use; and 
‘‘(III) illicit drug use by 
arrestees, probationers, and 
parolees. 
‘‘(viii) An assessment of the 
reduction of illicit drug avail-
ability, as measured by— 
‘‘(I) the quantities of co-
caine, 
heroin, 
marijuana, 
methamphetamine, 
ecstasy, 
and other drugs available for 
consumption in the United 
States; 
‘‘(II) the amount of mari-
juana, cocaine, heroin, meth-
amphetamine, 
ecstasy, 
and 
precursor 
chemicals 
and 
other 
drugs 
entering 
the 
United States; 
‘‘(III) the number of illicit 
drug manufacturing labora-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00044
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
tories seized and destroyed 
and the number of hectares of 
marijuana, poppy, and coca 
cultivated and destroyed do-
mestically and in other coun-
tries; 
‘‘(IV) the number of metric 
tons of marijuana, heroin, co-
caine, and methamphetamine 
seized and other drugs; and 
‘‘(V) changes in the price 
and purity of heroin, meth-
amphetamine, 
and 
cocaine, 
changes in the price of ec-
stasy, 
and 
changes 
in 
tetrahydrocannabinol level of 
marijuana and other drugs. 
‘‘(ix) An assessment of the re-
duction of the consequences of il-
licit drug use and availability, 
which shall include— 
‘‘(I) the burden illicit drug 
users place on hospital emer-
gency 
departments 
in 
the 
United States, such as the 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00045
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
quantity of illicit drug-related 
services provided; 
‘‘(II) the annual national 
health care cost of illicit drug 
use; and 
‘‘(III) the extent of illicit 
drug-related crime and crimi-
nal activity. 
‘‘(x) A general review of the 
status of, and trends in, of drug 
treatment in the United States, by 
assessing— 
‘‘(I) 
public 
and 
private 
treatment utilization; and 
‘‘(II) the number of illicit 
drug users the Director esti-
mates meet diagnostic criteria 
for treatment. 
‘‘(xi) A review of the research 
agenda of the Counterdrug Tech-
nology Assessment Center to re-
duce the availability and abuse of 
drugs. 
‘‘(xii) A summary of the efforts 
made by Federal agencies to co-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00046
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
ordinate with private sector enti-
ties to conduct private research 
and development of medications 
to treat addiction by— 
‘‘(I) screening chemicals 
for 
potential 
therapeutic 
value; 
‘‘(II) developing promising 
compounds; 
‘‘(III) conducting clinical 
trials; 
‘‘(IV) seeking, where ap-
propriate, Food and Drug Ad-
ministration 
approval 
for 
drugs to treat addiction; 
‘‘(V) marketing, where ap-
propriate, the drug for the 
treatment of addiction; 
‘‘(VI) 
urging 
physicians, 
where appropriate, to use the 
drug in the treatment of ad-
diction; and 
‘‘(VII) encouraging, where 
appropriate, insurance com-
panies to reimburse the cost 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00047
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
of the drug for the treatment 
of addiction. 
‘‘(xiii) Such additional statis-
tical data and information as the 
Director considers appropriate to 
demonstrate and assess trends re-
lating to illicit drug use, the ef-
fects and consequences of illicit 
drug use, supply reduction, de-
mand reduction, drug-related law 
enforcement, and the implementa-
tion of the National Drug Control 
Strategy. 
‘‘(xiv) A supplement reviewing 
the activities of each individual 
National Drug Control Program 
agency during the previous year 
with respect to the National Drug 
Control Strategy and the Direc-
tor’s assessment of the progress of 
each National Drug Control Pro-
gram agency in meeting its re-
sponsibilities under the National 
Drug Control Strategy. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00048
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
‘‘(B) 
CLASSIFIED
INFORMATION.— 
Any contents of the National Drug 
Control Strategy that involve infor-
mation properly classified under cri-
teria established by an Executive 
order shall be presented to Congress 
separately from the rest of the Na-
tional Drug Control Strategy. 
‘‘(C) SELECTION OF DATA AND INFOR-
MATION.—In selecting data and infor-
mation for inclusion under subpara-
graph (A), the Director shall ensure— 
‘‘(i) the inclusion of data and 
information that will permit anal-
ysis of current trends against pre-
viously compiled data and infor-
mation where the Director be-
lieves 
such 
analysis 
enhances 
long-term assessment of the Na-
tional Drug Control Strategy; and 
‘‘(ii) the inclusion of data and 
information to permit a standard-
ized and uniform assessment of 
the effectiveness of drug treat-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00049
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
ment programs in the United 
States. 
‘‘(3) PROCESS
FOR
DEVELOPMENT
AND 
SUBMISSION.— 
‘‘(A) 
CONSULTATION.—In 
devel-
oping and effectively implementing 
the National Drug Control Strategy, 
the Director— 
‘‘(i) shall consult with— 
‘‘(I) the heads of the Na-
tional Drug Control Program 
agencies; 
‘‘(II) Congress; 
‘‘(III) State and local offi-
cials; 
‘‘(IV) private citizens and 
organizations, 
including 
community- and faith-based 
organizations, 
with 
experi-
ence and expertise in demand 
reduction; 
‘‘(V) private citizens and 
organizations with experience 
and expertise in supply reduc-
tion; 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00050
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
‘‘(VI) private citizens and 
organizations with experience 
and expertise in law enforce-
ment; and 
‘‘(VII) 
appropriate 
rep-
resentatives of foreign gov-
ernments; 
‘‘(ii) with the concurrence of 
the Attorney General, may re-
quire the El Paso Intelligence 
Center 
to 
undertake 
specific 
tasks or projects to implement the 
National Drug Control Strategy; 
‘‘(iii) with the concurrence of 
the Director of National Intel-
ligence and the Attorney General, 
may request that the National 
Drug Intelligence Center under-
take specific tasks or projects to 
implement 
the 
National 
Drug 
Control Strategy; and 
‘‘(iv) may make recommenda-
tions to the Secretary of Health 
and Human Services on research 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00051
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
that supports or advances the Na-
tional Drug Control Strategy. 
‘‘(B) 
COMMITMENT
TO
SUPPORT 
STRATEGY.—In satisfying the require-
ments of subparagraph (A)(i), the Di-
rector shall ensure, to the maximum 
extent possible, that State and local 
officials and relevant private organi-
zations commit to support and take 
steps to achieve the goals and objec-
tives of the National Drug Control 
Strategy. 
‘‘(C) 
RECOMMENDATIONS.—Rec-
ommendations under subparagraph 
(A)(iv) may include recommendations 
of research to be performed at the 
National Institutes of Health, includ-
ing the National Institute on Drug 
Abuse, or any other appropriate agen-
cy within the Department of Health 
and Human Services. 
‘‘(D) INCLUSION IN STRATEGY.—The 
National 
Drug 
Control 
Strategy 
under this subsection shall include a 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00052
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
list of each entity consulted under 
subparagraph (A)(i). 
‘‘(4) SUBMISSION
OF
REVISED
STRAT-
EGY.—The President may submit to Con-
gress a revised National Drug Control 
Strategy that meets the requirements of 
this section— 
‘‘(A) at any time, upon a deter-
mination by the President, in con-
sultation with the Director, that the 
National Drug Control Strategy in ef-
fect is not sufficiently effective; or 
‘‘(B) if a new President or Direc-
tor takes office. 
‘‘(b) 
PERFORMANCE
MEASUREMENT
SYS-
TEM.—Not later than February 1 of each year, 
the Director shall submit to Congress, as part 
of the National Drug Control Strategy, a de-
scription of a national drug control perform-
ance measurement system that— 
‘‘(1) develops 2-year and 5-year per-
formance measures and targets for each 
National Drug Control Strategy goal and 
objective established for reducing drug 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00053
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
use, drug 
availability, 
and 
the 
con-
sequences of drug use; 
‘‘(2) describes the sources of informa-
tion and data that will be used for each 
performance measure incorporated into 
the performance measurement system; 
‘‘(3) identifies major programs and ac-
tivities of the National Drug Control Pro-
gram agencies that support the goals and 
annual objectives of the National Drug 
Control Strategy; 
‘‘(4) evaluates the contribution of de-
mand reduction and supply reduction ac-
tivities implemented by each National 
Drug Control Program agency in support 
of the National Drug Control Strategy; 
‘‘(5) monitors consistency of drug-re-
lated goals and objectives among the Na-
tional Drug Control Program agencies 
and ensures that each agency’s goals, ob-
jectives, and budgets support and are 
fully consistent with the National Drug 
Control Strategy; and 
‘‘(6) coordinates the development and 
implementation of national drug control 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00054
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
data collection and reporting systems to 
support policy formulation and perform-
ance measurement, including an assess-
ment of— 
‘‘(A) the quality of current drug 
use measurement instruments and 
techniques to measure supply reduc-
tion and demand reduction activities; 
‘‘(B) the adequacy of the coverage 
of existing national drug use meas-
urement instruments and techniques 
to measure the illicit drug user popu-
lation, and groups that are at risk for 
illicit drug use; and 
‘‘(C) the adequacy of the coverage 
of existing national treatment out-
come monitoring systems to measure 
the effectiveness of drug abuse treat-
ment in reducing illicit drug use and 
criminal behavior during and after 
the completion of substance abuse 
treatment; and 
‘‘(7) identifies the actions the Director 
shall take to correct any inadequacies, 
deficiencies, or limitations identified in 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00055
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
the assessment described in paragraph 
(6). 
‘‘(c) MODIFICATIONS.—A description of any 
modifications made during the preceding 
year to the national drug performance meas-
urement system described in subsection (b) 
shall be included in each report submitted 
under subsection (a).’’. 
SEC. 109. HIGH INTENSITY DRUG TRAFFICKING AREAS 
PROGRAM. 
Section 707 (21 U.S.C. 1706) is amended to 
read as follows: 
‘‘SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS 
PROGRAM. 
‘‘(a) ESTABLISHMENT.— 
‘‘(1) IN GENERAL.—There is established 
in the Office a program to be known as 
the 
High 
Intensity 
Drug 
Trafficking 
Areas Program (in this section referred 
to as the ‘Program’). 
‘‘(2) PURPOSE.—The purpose of the 
Program is to reduce drug trafficking 
and drug production in the United States 
by— 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00056
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
‘‘(A) 
facilitating 
cooperation 
among Federal, State, and local law 
enforcement agencies to share infor-
mation and implement coordinated 
enforcement activities; 
‘‘(B) enhancing intelligence shar-
ing among Federal, State, and local 
law enforcement agencies; 
‘‘(C) 
providing 
reliable 
intel-
ligence to law enforcement agencies 
needed to design effective enforce-
ment strategies and operations; and 
‘‘(D) supporting coordinated law 
enforcement strategies which maxi-
mize use of available resources to re-
duce the supply of illegal drugs in 
designated areas and in the United 
States as a whole. 
‘‘(b) DESIGNATION.—The Director, upon 
consultation with the Attorney General, the 
Secretary of the Treasury, the Secretary of 
Homeland Security, heads of the National 
Drug Control Program agencies, and the Gov-
ernor of each applicable State, may designate 
any specified area of the United States as a 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00057
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
high intensity drug trafficking area. After 
making such a designation and in order to 
provide Federal assistance to the area so des-
ignated, the Director may— 
‘‘(1) obligate such sums as are appro-
priated for the Program; 
‘‘(2) direct the temporary reassign-
ment of Federal personnel to such area, 
subject to the approval of the head of the 
department or agency that employs such 
personnel; 
‘‘(3) take any other action authorized 
under section 704 to provide increased 
Federal assistance to those areas; and 
‘‘(4) coordinate activities under this 
section (specifically administrative, rec-
ordkeeping, and funds management ac-
tivities) with State and local officials. 
‘‘(c) PETITIONS FOR DESIGNATION.—The Di-
rector shall establish regulations under which 
a coalition of interested law enforcement 
agencies from an area may petition for des-
ignation as a high intensity drug trafficking 
area. Such regulations shall provide for a reg-
ular review by the Director of the petition, in-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00058
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
cluding a recommendation regarding the 
merit of the petition to the Director by a 
panel of qualified, independent experts. 
‘‘(d) FACTORS FOR CONSIDERATION.—In con-
sidering whether to designate an area under 
this section as a high intensity drug traf-
ficking area, the Director shall consider, in 
addition to such other criteria as the Director 
considers to be appropriate, the extent to 
which— 
‘‘(1) the area is a significant center of 
illegal drug production, manufacturing, 
importation, or distribution; 
‘‘(2) State and local law enforcement 
agencies have committed resources to re-
spond to the drug trafficking problem in 
the area, thereby indicating a determina-
tion to respond aggressively to the prob-
lem; 
‘‘(3) drug-related activities in the area 
are having a significant harmful impact 
in the area, and in other areas of the 
country; and 
‘‘(4) a significant increase in alloca-
tion of Federal resources is necessary to 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00059
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
respond adequately to drug-related ac-
tivities in the area. 
‘‘(e) ORGANIZATION
OF
HIGH
INTENSITY 
DRUG TRAFFICKING AREAS.— 
‘‘(1) EXECUTIVE BOARD AND OFFICERS.— 
To be eligible for funds appropriated 
under this section, each high intensity 
drug trafficking area shall be governed 
by an Executive Board. The Executive 
Board shall designate a chairman, vice 
chairman, and any other officers to the 
Executive Board that it determines are 
necessary. 
‘‘(2) RESPONSIBILITIES.—The Executive 
Board of a high intensity drug trafficking 
area shall be responsible for— 
‘‘(A) providing direction and over-
sight in establishing and achieving 
the goals of the high intensity drug 
trafficking area; 
‘‘(B) managing the funds of the 
high intensity drug trafficking area; 
‘‘(C) reviewing and approving all 
funding proposals consistent with the 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00060
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
overall objective of the high intensity 
drug trafficking area; and 
‘‘(D) reviewing and approving all 
reports to the Director on the activi-
ties of the high intensity drug traf-
ficking area. 
‘‘(3) BOARD REPRESENTATION.—None of 
the funds appropriated under this section 
may be expended for any high intensity 
drug trafficking area, or for a partner-
ship or region of a high intensity drug 
trafficking area, if that area’s, region’s or 
partnership’s Executive Board does not 
apportion an equal number of votes be-
tween representatives of participating 
Federal agencies and representatives of 
participating State and local agencies. 
Where it is impractical for a equal num-
ber of representatives of Federal agen-
cies and State and local agencies to at-
tend a meeting of an Executive Board in 
person, the Executive Board may use a 
system of proxy votes or weighted votes 
to achieve the voting balance required by 
this paragraph. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00061
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
‘‘(4) NO
AGENCY
RELATIONSHIP.—The 
eligibility requirements of this section 
are intended to ensure the responsible 
use of Federal funds. Nothing in this sec-
tion is intended to create an agency rela-
tionship between individual high inten-
sity drug trafficking areas and the Fed-
eral Government. 
‘‘(f) USE OF FUNDS.—The Director shall en-
sure that no Federal funds appropriated for 
the Program are expended for the establish-
ment or expansion of drug treatment or drug 
use prevention programs. 
‘‘(g) COUNTERTERRORISM ACTIVITIES.— 
‘‘(1) ASSISTANCE AUTHORIZED.—The Di-
rector may authorize use of resources 
available for the Program to assist Fed-
eral, State, and local law enforcement 
agencies in investigations and activities 
related to terrorism and prevention of 
terrorism, especially but not exclusively 
with respect to such investigations and 
activities that are also related to drug 
trafficking. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00062
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
‘‘(2) LIMITATION.—The Director shall 
ensure— 
‘‘(A) 
that 
assistance 
provided 
under paragraph (1) remains inci-
dental to the purpose of the Program 
to reduce drug availability and carry 
out drug-related law enforcement ac-
tivities; and 
‘‘(B) that significant resources of 
the Program are not redirected to ac-
tivities exclusively related to ter-
rorism, except on a temporary basis 
under extraordinary circumstances, 
as determined by the Director. 
‘‘(h) ROLE OF DRUG ENFORCEMENT ADMINIS-
TRATION.—The Director, in consultation with 
the Attorney General, shall ensure that a rep-
resentative of the Drug Enforcement Adminis-
tration is included in the Intelligence Support 
Center for each high intensity drug traf-
ficking area. 
‘‘(i) ANNUAL HIDTA PROGRAM BUDGET SUB-
MISSIONS.—As part of the documentation that 
supports the President’s annual budget re-
quest for the Office, the Director shall submit 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00063
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
to Congress a budget justification that in-
cludes the following: 
‘‘(1) The amount requested for each 
high intensity drug trafficking area with 
supporting narrative descriptions and ra-
tionale for each request. 
‘‘(2) A detailed justification for each 
funding request that explains the reasons 
for the requested funding level, how such 
funding level was determined based on a 
current assessment of the drug traf-
ficking threat in each high intensity drug 
trafficking area, how such funding will 
ensure that the goals and objectives of 
each such area will be achieved, and how 
such funding supports the National Drug 
Control Strategy. 
‘‘(j) EMERGING THREAT RESPONSE FUND.— 
‘‘(1) IN
GENERAL.—The Director may 
expend up to 10 percent of the amounts 
appropriated under this section on a dis-
cretionary basis, to respond to any 
emerging drug trafficking threat in an 
existing high intensity drug trafficking 
area, or to establish a new high intensity 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00064
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
drug trafficking area or expand an exist-
ing high intensity drug trafficking area, 
in accordance with the criteria estab-
lished under paragraph (2). 
‘‘(2) CONSIDERATION OF IMPACT.—In al-
locating funds under this subsection, the 
Director shall consider— 
‘‘(A) the impact of activities fund-
ed on reducing overall drug traffic in 
the United States, or minimizing the 
probability that an emerging drug 
trafficking threat will spread to other 
areas of the United States; and 
‘‘(B) such other criteria as the Di-
rector considers appropriate. 
‘‘(k) EVALUATION.— 
‘‘(1) INITIAL
REPORT.—Not later than 
90 days after the date of the enactment of 
this subsection, the Director shall, after 
consulting with the Executive Boards of 
each designated high intensity drug traf-
ficking area, submit a report to Congress 
that describes, for each designated high 
intensity drug trafficking area— 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00065
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
‘‘(A) the specific purposes for the 
high intensity drug trafficking area; 
‘‘(B) the specific long-term and 
short-term goals and objectives for 
the high intensity drug trafficking 
area; 
‘‘(C) the measurements that will 
be used to evaluate the performance 
of the high intensity drug trafficking 
area in achieving the long-term and 
short-term goals; and 
‘‘(D) the reporting requirements 
needed to evaluate the performance 
of the high intensity drug trafficking 
area in achieving the long-term and 
short-term goals. 
‘‘(2) EVALUATION OF HIDTA PROGRAM AS 
PART
OF
NATIONAL
DRUG
CONTROL
STRAT-
EGY.—For each designated high intensity 
drug trafficking area, the Director shall 
submit, as part of the annual National 
Drug Control Strategy report, a report 
that— 
‘‘(A) describes— 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00066
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
‘‘(i) the specific purposes for 
the 
high 
intensity 
drug 
traf-
ficking area; and 
‘‘(ii) 
the 
specific 
long-term 
and short-term goals and objec-
tives for the high intensity drug 
trafficking area; and 
‘‘(B) includes an evaluation of the 
performance of the high intensity 
drug 
trafficking 
area 
in 
accom-
plishing the specific long-term and 
short-term goals and objectives iden-
tified under paragraph (1)(B). 
‘‘(l) ASSESSMENT
OF DRUG ENFORCEMENT 
TASK FORCES IN HIGH INTENSITY DRUG TRAF-
FICKING AREAS.—Not later than 180 days after 
the date of enactment of this subsection, and 
as part of each subsequent annual National 
Drug Control Strategy report, the Director 
shall submit to Congress a report— 
‘‘(1) assessing the number and oper-
ation of all federally funded drug en-
forcement task forces within each high 
intensity drug trafficking area; and 
‘‘(2) describing— 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00067
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
‘‘(A) each Federal, State, and local 
drug enforcement task force oper-
ating in the high intensity drug traf-
ficking area; 
‘‘(B) how such task forces coordi-
nate with each other, with any high 
intensity drug trafficking area task 
force, and with investigations receiv-
ing funds from the Organized Crime 
and Drug Enforcement Task Force; 
‘‘(C) what steps, if any, each such 
task force takes to share information 
regarding drug trafficking and drug 
production with other federally fund-
ed drug enforcement task forces in 
the high intensity drug trafficking 
area; 
‘‘(D) the role of the high intensity 
drug trafficking area in coordinating 
the 
sharing 
of 
such 
information 
among task forces; 
‘‘(E) the nature and extent of co-
operation by each Federal, State, and 
local participant in ensuring that 
such information is shared among 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00068
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
law enforcement agencies and with 
the high intensity drug trafficking 
area; 
‘‘(F) the nature and extent to 
which information sharing and en-
forcement activities are coordinated 
with joint terrorism task forces in the 
high intensity drug trafficking area; 
and 
‘‘(G) any recommendations for 
measures needed to ensure that task 
force resources are utilized efficiently 
and effectively to reduce the avail-
ability of illegal drugs in the high in-
tensity drug trafficking areas. 
‘‘(m) ASSESSMENT OF INTELLIGENCE SHARING 
IN HIGH INTENSITY DRUG TRAFFICKING AREAS— 
PROGRAM.—Not later than 180 days after the 
date of the enactment of this subsection, and 
as part of each subsequent annual National 
Drug Control Strategy report, the Director 
shall submit to Congress a report— 
‘‘(1) evaluating existing and planned 
intelligence systems supported by each 
high intensity drug trafficking area, or 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00069
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
utilized by task forces receiving any 
funding under the Program, including 
the extent to which such systems ensure 
access and availability of intelligence to 
Federal, State, and local law enforcement 
agencies within the high intensity drug 
trafficking area and outside of it; 
‘‘(2) the extent to which Federal, 
State, and local law enforcement agencies 
participating in each high intensity drug 
trafficking area are sharing intelligence 
information to assess current drug traf-
ficking threats and design appropriate 
enforcement strategies; and 
‘‘(3) the measures needed to improve 
effective sharing of information and in-
telligence regarding drug trafficking and 
drug production among Federal, State, 
and local law enforcement participating 
in a high intensity drug trafficking area, 
and between such agencies and similar 
agencies outside the high intensity drug 
trafficking area. 
‘‘(n) AUTHORIZATION OF APPROPRIATIONS.— 
There is authorized to be appropriated to the 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00070
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
Office of National Drug Control Policy to 
carry out this section— 
‘‘(1) $280,000,000 for fiscal year 2006; 
‘‘(2) $290,000,000 for each of fiscal 
years 2007 and 2008; and 
‘‘(3) $300,000,000 for each of fiscal 
years 2009 and 2010.’’. 
SEC. 110. FUNDING FOR CERTAIN HIGH INTENSITY DRUG 
TRAFFICKING AREAS. 
(a) SHORT TITLE.—This section may be 
cited as the ‘‘Dawson Family Community Pro-
tection Act’’. 
(b) FINDINGS.—Congress finds the fol-
lowing: 
(1) In the early morning hours of Oc-
tober 16, 2002, the home of Carnell and 
Angela Dawson was firebombed in appar-
ent retaliation for Mrs. Dawson’s notifica-
tion of police about persistent drug dis-
tribution activity in their East Baltimore 
City neighborhood. 
(2) The arson claimed the lives of Mr. 
and Mrs. Dawson and their 5 young chil-
dren, aged 9 to 14. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00071
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
(3) The horrific murder of the Daw-
son family is a stark example of domestic 
narco-terrorism. 
(4) In all phases of counter-narcotics 
law enforcement—from prevention to in-
vestigation to prosecution to reentry—the 
voluntary cooperation of ordinary citi-
zens is a critical component. 
(5) Voluntary cooperation is difficult 
for law enforcement officials to obtain 
when citizens feel that cooperation car-
ries the risk of violent retaliation by ille-
gal drug trafficking organizations and 
their affiliates. 
(6) Public confidence that law en-
forcement is doing all it can to make 
communities safe is a prerequisite for 
voluntary cooperation among people who 
may be subject to intimidation or reprisal 
(or both). 
(7) Witness protection programs are 
insufficient on their own to provide secu-
rity because many individuals and fami-
lies who strive every day to make dis-
tressed neighborhoods livable for their 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00072
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
children, other relatives, and neighbors 
will resist or refuse offers of relocation 
by local, State, and Federal prosecutorial 
agencies and because, moreover, the con-
tinued presence of strong individuals and 
families is critical to preserving and 
strengthening the social fabric in such 
communities. 
(8) Where (as in certain sections of 
Baltimore City) interstate trafficking of 
illegal drugs has severe ancillary local 
consequences within areas designated as 
high intensity drug trafficking areas, it is 
important that supplementary High In-
tensity Drug Trafficking Areas Program 
funds be committed to support initiatives 
aimed at making the affected commu-
nities safe for the residents of those com-
munities and encouraging their coopera-
tion with local, State, and Federal law en-
forcement efforts to combat illegal drug 
trafficking. 
(c) FUNDING FOR CERTAIN HIGH INTENSITY 
DRUG TRAFFICKING AREAS.—Section 707 (21 
U.S.C. 1706), as amended by section 109, is fur-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00073
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
ther amended by adding at the end the fol-
lowing new subsection: 
‘‘(o) SPECIFIC PURPOSES.— 
‘‘(1) IN GENERAL.—The Director shall 
ensure that, of the amounts appropriated 
for a fiscal year for the Program, at least 
$5,000,000 is used in high intensity drug 
trafficking areas with severe neighbor-
hood safety and illegal drug distribution 
problems. 
‘‘(2) REQUIRED USES.—The funds used 
under paragraph (1) shall be used— 
‘‘(A) to ensure the safety of neigh-
borhoods and the protection of com-
munities, including the prevention of 
the intimidation of potential wit-
nesses of illegal drug distribution and 
related activities; and 
‘‘(B) to combat illegal drug traf-
ficking through such methods as the 
Director considers appropriate, such 
as establishing or operating (or both) 
a toll-free telephone hotline for use 
by the public to provide information 
about illegal drug-related activities.’’. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00074
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
SEC. 111. AMENDMENTS RELATING TO COUNTER-DRUG 
TECHNOLOGY ASSESSMENT CENTER. 
(a) CHIEF SCIENTIST.—Section 708(b) (21 
U.S.C. 1707(b)) is amended— 
(1) in the heading by striking ‘‘DIREC-
TOR
OF
TECHNOLOGY.—’’ and inserting 
‘‘CHIEF SCIENTIST.—’’; and 
(2) by striking ‘‘Director of Tech-
nology,’’ and inserting ‘‘Chief Scientist,’’. 
(b) ADDITIONAL RESPONSIBILITIES OF DIREC-
TOR.—Section 708(c) (21 U.S.C. 1707(c)) is 
amended to read as follows: 
‘‘(c) ADDITIONAL RESPONSIBILITIES OF THE 
DIRECTOR
OF NATIONAL DRUG CONTROL POL-
ICY.— 
‘‘(1) IN GENERAL.—The Director, acting 
through the Chief Scientist shall— 
‘‘(A) 
identify 
and 
define 
the 
short-, medium-, and long-term sci-
entific and technological needs of 
Federal, State, and local law enforce-
ment agencies relating to drug en-
forcement, including— 
‘‘(i) 
advanced 
surveillance, 
tracking, and radar imaging; 
VerDate Aug 31 2005 
00:17 Mar 04, 2006
Jkt 049200
PO 00000
Frm 00075
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
‘‘(ii) electronic support meas-
ures; 
‘‘(iii) communications; 
‘‘(iv) data fusion, advanced 
computer systems, and artificial 
intelligence; and 
‘‘(v) chemical, biological, radi-
ological (including neutron, elec-
tron, and graviton), and other 
means of detection; 
‘‘(B) identify demand reduction 
(including drug prevention) basic and 
applied research needs and initia-
tives, in consultation with affected 
National Drug Control Program agen-
cies, including— 
‘‘(i) 
improving 
treatment 
through neuroscientific advances; 
‘‘(ii) improving the transfer of 
biomedical research to the clin-
ical setting; and 
‘‘(iii) in consultation with the 
National Institute on Drug Abuse 
and the Substance Abuse and 
Mental Health Services Adminis-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00076
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
tration, and through interagency 
agreements or grants, examining 
addiction and rehabilitation re-
search and the application of 
technology to expanding the ef-
fectiveness or availability of drug 
treatment; 
‘‘(C) make a priority ranking of 
such needs identified in subpara-
graphs (A) and (B) according to fiscal 
and technological feasibility, as part 
of a National Counterdrug Research 
and Development Program; 
‘‘(D) 
oversee 
and 
coordinate 
counterdrug 
technology 
initiatives 
with related activities of other Fed-
eral civilian and military depart-
ments; 
‘‘(E) provide support to the devel-
opment and implementation of the 
national drug control performance 
measurement 
system 
established 
under subsection (b) of section 706; 
‘‘(F) with the advice and counsel 
of experts from State and local law 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00077
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
enforcement agencies, oversee and 
coordinate a technology transfer pro-
gram for the transfer of technology to 
State 
and 
local 
law 
enforcement 
agencies; and 
‘‘(G) pursuant to the authority of 
the Director of National Drug Control 
Policy under section 704, submit re-
quests to Congress for the reprogram-
ming or transfer of funds appro-
priated for counterdrug technology 
research and development. 
‘‘(2) PRIORITIES IN TRANSFERRING TECH-
NOLOGY.— 
‘‘(A) IN GENERAL.—The Chief Sci-
entist shall give priority, in transfer-
ring 
technology 
under 
paragraph 
(1)(F), based on the following criteria: 
‘‘(i) the need of potential re-
cipients for such technology; 
‘‘(ii) the effectiveness of the 
technology to enhance current 
counterdrug activities of poten-
tial recipients; and 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00078
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
‘‘(iii) the ability and willing-
ness of potential recipients to 
evaluate transferred technology. 
‘‘(B) 
INTERDICTION
AND
BORDER 
DRUG
LAW
ENFORCEMENT
TECH-
NOLOGIES.—The Chief Scientist shall 
give priority, in transferring tech-
nologies most likely to assist in drug 
interdiction and border drug law en-
forcement, to State, local, and tribal 
law enforcement agencies in south-
west border areas and northern bor-
der areas with significant traffic in il-
licit drugs. 
‘‘(3) LIMITATION
ON
AUTHORITY.—The 
authority granted to the Director under 
this subsection shall not extend to the di-
rect management of individual projects 
or other operational activities. 
‘‘(4) REPORT.—On or before July 1 of 
each year, the Director shall submit a re-
port to the appropriate congressional 
committees that addresses the following: 
‘‘(A) The number of requests re-
ceived 
during 
the 
previous 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00079
Fmt 6652
Sfmt 6202
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS